Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation TCT 2016

STICH and STICHES Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, James E. Udelson

October 31, 2016

Presentation TCT 2016

Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up

Presenter: Sunil V. Rao, Harvey D. White, Robert A. Guyton

October 31, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

Presentation ESC 2016

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Presenter: Eric Velazquez

August 29, 2016

News Daily News

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Todd Neale

July 25, 2016

News Features

From Chaos to Consistency: How One Michigan Hospital Built a Heart Team That Works

Yael L. Maxwell

April 27, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Industry News

First BioVentrix Revivent® System Clinical Patients Sustain 39.6% Improvement in Heart Function at One Year

June 27, 2013

News Daily News

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

L.A. McKeown

March 09, 2013

News Industry News

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

January 27, 2013

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

Advertisement

STICH and STICHES Critique: Pros and Cons

Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

From Chaos to Consistency: How One Michigan Hospital Built a Heart Team That Works

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

First BioVentrix Revivent® System Clinical Patients Sustain 39.6% Improvement in Heart Function at One Year

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content